| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439178A1 Template-fixed peptidomimetics with antimicrobial activity |
| 09/12/2002 | CA2439042A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | CA2438863A1 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine |
| 09/12/2002 | CA2437398A1 Molecules for disease detection and treatment |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | CA2427113A1 Novel human 7tm proteins and polynucleotides encoding the same |
| 09/11/2002 | EP1239051A2 Human posh-like protein 1 |
| 09/11/2002 | EP1239047A2 Method for producing proteins |
| 09/11/2002 | EP1239044A1 Production of genetically modified plants with puroindolines |
| 09/11/2002 | EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor |
| 09/11/2002 | EP1239040A2 Mutations in the rpoB gene of L-lysine producing Corynebacterium glutamicum strains and process for the preparation of L-lysine |
| 09/11/2002 | EP1239039A1 Novel polypeptide and dna thereof |
| 09/11/2002 | EP1239038A1 High-throughput identification of modulators of e2f activity |
| 09/11/2002 | EP1239037A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 09/11/2002 | EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 09/11/2002 | EP1239035A1 Novel protein and gene |
| 09/11/2002 | EP1239033A1 Semaphorin receptor |
| 09/11/2002 | EP1238986A2 Use of Vascular endothelial cell growth factor antagonists |
| 09/11/2002 | EP1238984A1 54498, an amino acid transporter and uses therefor |
| 09/11/2002 | EP1238983A1 "Babesia canis vaccine" |
| 09/11/2002 | EP1238982A1 A Fluorescent Protein |
| 09/11/2002 | EP1238674A2 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238279A1 Helicobacter pylori antigens in blood |
| 09/11/2002 | EP1238275A1 Characterization of hybridized polymer molecules based on monomer-interface interactions |
| 09/11/2002 | EP1238113A2 Supracolonic aerodigestive neoplasm detection |
| 09/11/2002 | EP1238104A2 Agents implicated in endometriosis |
| 09/11/2002 | EP1238095A2 Compositions and methods for caspase-induced apoptosis |
| 09/11/2002 | EP1238089A2 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 09/11/2002 | EP1238088A2 Insecticide targets and methods of use |
| 09/11/2002 | EP1238087A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 09/11/2002 | EP1238085A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238082A2 Ifn-alpha homologues |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238079A2 Wasp family protein fragments, and use thereof |
| 09/11/2002 | EP1238078A2 Clasp-4 transmembrane protein |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238076A2 G protein-coupled receptor-like receptors and modulators thereof |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238074A2 Molecules of the card-related protein family and uses thereof |
| 09/11/2002 | EP1238073A2 A eag gene encoding for a potassium channel |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238061A2 A new genotype of hepatitis b virus |
| 09/11/2002 | EP1238058A2 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 09/11/2002 | EP1238056A2 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM |
| 09/11/2002 | EP1237936A1 Molecularly inprinted polymers produced by template polymerisation |
| 09/11/2002 | EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 09/11/2002 | EP1237929A1 Dendritic cell-specific antibodies |
| 09/11/2002 | EP1237927A2 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 09/11/2002 | EP1237925A1 MUTANT ER$g(a) AND TEST SYSTEMS FOR TRANSACTIVATION |
| 09/11/2002 | EP1237924A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 09/11/2002 | EP1237923A2 Human ion channels |
| 09/11/2002 | EP1237922A2 Proteoglycans and pharmaceutical compositions comprising them |
| 09/11/2002 | EP1237921A1 Umlr polypeptides |
| 09/11/2002 | EP1237920A2 A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a) |
| 09/11/2002 | EP1237919A1 Interferon-alpha induced gene |
| 09/11/2002 | EP1237918A2 A gene, disrupted in schizophrenia |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237914A1 Methods for improving secondary metabolite production in fungi |
| 09/11/2002 | EP1237913A2 Antigen preparations |
| 09/11/2002 | EP1237912A2 Five-helix protein |
| 09/11/2002 | EP1237911A2 Inhibition of hrsv membrane fusion |
| 09/11/2002 | EP1237910A2 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 09/11/2002 | EP1237909A2 Human g protein-coupled receptors |
| 09/11/2002 | EP1237907A2 Complementary peptide ligands generated from the human genome |
| 09/11/2002 | EP1237906A2 Complementary peptide ligands generated from plant genomes |
| 09/11/2002 | EP1237905A2 Complementary peptide ligands generated from microbial genome sequences |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
| 09/11/2002 | EP1237572A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 09/11/2002 | EP1237571A2 Toscana virus nucleoprotein |
| 09/11/2002 | EP1237568A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 09/11/2002 | EP1237564A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/11/2002 | EP1237547A2 Compounds for inhibiting diseases and preparing cells for transplantation |
| 09/11/2002 | EP1237405A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 09/11/2002 | EP1237403A1 Method of usinf mapk4 and orthologues thereof to control plant disease and plantgrowth |
| 09/11/2002 | EP1189944A4 Axor16, a g protein coupled receptor |
| 09/11/2002 | EP1080158B1 Adhesives |
| 09/11/2002 | EP1003539A4 FLUORESCENT AMYLOID A beta PEPTIDES AND USES THEREOF |
| 09/11/2002 | EP0954527A4 Glycine transporter-transfected cells and uses thereof |
| 09/11/2002 | EP0853484B1 Novel mu opioid receptor ligands: agonists and antagonists |
| 09/11/2002 | EP0832098B1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
| 09/11/2002 | EP0762870B1 Virosome-mediated intracellular delivery of therapeutic agents |
| 09/11/2002 | EP0603399B1 Endothelin-antagonizing peptide |
| 09/11/2002 | CN1369011A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 09/11/2002 | CN1369010A Compositions affecting programmed cell death and their use in-modification of forestry plant development |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368978A Novel proteins and uses thereof |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368511A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368510A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368509A Human protein with suppression to cancer cell growth and its coding sequence |